47
total announcements
MEDANTA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹34,396 Cr
P/E (TTM)
61.9
P/E (Forward)
38.1
EPS (TTM)
₹20.68
52W Low
₹956.00
52W High
₹1,544.00
Dividend Yield
0.04%
Beta
0.16
Price / Book
8.7
Debt / Equity
29.9
Revenue (TTM)
₹4,683 Cr
Gross Margin
52.79%
Operating Margin
16.70%
Global Health Limited
Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, with no securities dematerialized or rematerialized during the quarter ended September 30, 2026.
Global Health Limited
Global Health Limited has received an ESG rating of 'Crisil ESG 64' and Core ESG rating of 'Crisil Core ESG 70' for the Fiscal Year 2026 from Crisil ESG Ratings & Analytics Limited.
Global Health Limited
Global Health Limited, the parent company of Medanta, has announced the acquisition of a 10,560 sq. metre land parcel in Ghaziabad, Uttar Pradesh, for approximately ₹165.82 crore. The land parcel is expected to accommodate a 350+ bedded hospital, subject to customary and statutory approvals.
Global Health Limited
Global Health Limited has been allotted a land parcel from UP Housing & Development Board for approximately Rs 165.82 crores to construct a 350+ bedded hospital, subject to approvals.
Global Health Limited
Global Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled analyst/institutional investor meeting on September 25, 2026, with Arohi Asset Management One to One Virtual.
Global Health Limited
Global Health Limited has informed the Exchange regarding allotment of 3000 securities pursuant to ESOP/ESPS at its meeting held on September 22, 2026.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting to be held on September 23, 2026, in Gurugram.
Global Health Limited
Global Health Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 16, 2026, and informed the Exchange regarding voting results.
Global Health Limited
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026, through video conferencing. The meeting was attended by the Chairman, Directors, and officials. The company's financial statements for the year ended March 31, 2026, were adopted, and a final dividend of ₹ 0.50 per Equity Share was declared. The meeting also approved the remuneration of the Cost Auditors for the financial year 2026-27.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of analysts/institutional investor meetings to be held on September 17 and 18, 2026, in Gurugram and Mumbai respectively, where the company's management will meet investors and analysts.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of analysts/institutional investor meetings to be held on September 17 and 18, 2026, in Gurugram and Mumbai respectively.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with investors/analysts on September 15, 2026, in Noida, organized by Jefferies. The meeting is not expected to share any unpublished price-sensitive information.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with investors/analysts on September 14, 2026, in Lucknow, to be held in person. The meeting is organized by Jefferies and is subject to change due to unforeseen circumstances.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of an Analysts/Institutional Investors Meeting to be held on September 10 and 14, 2026, in Gurugram, with no unpublished price sensitive information to be shared.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of an Analysts/Institutional Investors Meeting, to be held on September 10 and 14, 2026, in Gurugram, with no unpublished price sensitive information to be shared.
Global Health Limited
Global Health Limited has informed the Exchange about the schedule of an Analysts/Institutional Investors Meeting to be held on September 8, 2026, in Gurugram, where the company's management will meet investors and analysts.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with investors and analysts on August 31, 2026, in Noida, where no unpublished price-sensitive information will be shared.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with investors and analysts on August 26 and 27, 2026, to be held in a physical mode.
Global Health Limited
Global Health Limited has informed the Exchange about a scheduled meeting with analysts and institutional investors on August 26 and 27, 2026, to discuss the company's performance and future prospects.